Skip to main content
. 2024 Jan 19;12(1):232. doi: 10.3390/biomedicines12010232
AA allergic asthma
ATX autotaxin
BAC bronchial allergen challenge
ELISA enzyme-linked immunosorbent assay
EOS eosinophil
FeNO fractional exhaled nitric oxide
FEV1 forced expiratory volume in 1 s
HSs healthy subjects
ICTP I C-telopeptide of type I collagen
IgE immunoglobulin E
IL-5 interleukin-5
Lp-PLA2 lipoprotein-associated phospholipase A2
LSMU Lithuanian University of Health Sciences
MMP-10 matrix metalloproteinase-10
MMP-7 matrix metalloproteinase-7
MMP-9 matrix metalloproteinase-9
PTX3 pentraxin 3
ROC receiver operating characteristic
sIL-5Rα soluble interleukin 5 receptor subunit alpha
T2 type 2
TRX1 thioredoxin 1
V1 experimental day
V2 experimental day—24 h after V1.